Phase 3 Cardiopulmonary Bypass Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
CSL Behring200 enrolled19 locationsNCT07094087
Recruiting
Phase 3
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
Cardiac SurgeryCardiopulmonary BypassNitric Oxide+1 more
Xijing Hospital3,650 enrolled3 locationsNCT06702553
Active
Phase 3
SNUG-2: Studying Neurons Using Glypromate® - Second Study
Cardiopulmonary bypass (CPB) procedures for coronary bypass grafting (CABG) and/or valve replacement/repair due to the significant incidence of neurocognitive changes following such surgery
Neuren Pharmaceuticals Ltd355 enrolled2 locationsACTRN12608000168358
Not Yet Recruiting
Phase 3
Improving blood coagulation function and reducing blood loss in infants after open heart surgery
Haemostasis during and after paediatric cardiopulmonary bypass
Royal Childrens Hospital and Murdoch Children's Research Institute80 enrolled1 locationACTRN12606000057583